+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Global qPCR and dPCR Market Forecast up to 2025

  • ID: 4751904
  • Report
  • February 2019
  • Region: Global
  • 93 Pages
  • Infoholic Research LLP
10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now


  • Abbott Laboratories
  • Agilent Technologies Inc.
  • BioMerieux S.A.
  • Bio-Rad Laboratories
  • Danaher Corp. (Cepheid)
  • Eppendorf AG
  • MORE

This market research report includes a detailed segmentation of the global qPCR and dPCR market – By Technology Type (qPCR and dPCR), By Product Type (Instruments, Reagents & Consumables, and Software & Services), By Application (Clinical Diagnostics, Biomedical Research, and Others), By End Users (Hospitals & Laboratories, Pharmaceutical Companies, Academics, and Others), By Region (North America, Europe, Asia Pacific, and Rest of the World).

Overview of the Global qPCR and dPCR Market Research
The research report predicts that the global qPCR and dPCR market will grow at a CAGR of 9.2% during the forecast period. The market has witnessed steady growth in the past few years and development in technology with the introduction of highly sensitive, robust, and reliable systems in the market. The market is fueled by rising demand for qPCR and dPCR in genetic and molecular testing, increasing private investment and funds, and increasing demand for biomarker-based tests.
The market continues to grow and is one of the most widely used technology for the quantification of nucleic acid. The advanced technology has made the device simple, fast, and accurate. Vendors are focusing towards new product launches and targeting towards end-users perspective. The majority of the revenue is generated from the leading players in the market with dominating sales of Thermo Fisher Scientific, Bio-Rad Laboratories, Qiagen N.V., Abbott Laboratories, Danaher Corporation and F. Hoffmann-La Roche Ltd.

According to the authors research analysis, North America accounted for the largest share of the global qPCR and dPCR market in 2018. The increased usage of PCR in proteomics & genomics, advanced technologies such as qPCR and PCR-based laboratory developed tests for rare genetic diseases, cancers, and infectious diseases are driving the market in North America. The Asia Pacific region is expected to witness the fastest growth rate due to large patient pool and rising healthcare expenditure.

By Product Type:

  • Instruments
  • Reagents and Consumables
  • Software and Services

In 2018, the reagents and consumables segment occupied the largest share due to its advanced features and specialty-based operations. Many companies are focusing on providing even software services. In March 2017, ThermoFisher Scientific acquired Core Informatics, a provider of cloud-based platform supporting scientific data management.

By Applications:

  • Clinical Diagnostics
  • Biomedical Research
  • Others

In 2018, the biomedical research accounted the maximum share followed by the clinical diagnostics. The successful completion of Human genome project has driven the growth of qPCR and dPCR market.

By Technology Type:

  • Qualitative PCR
  • Digital PCR

qPCR has become the standard method for quantification of gene expression. Its high sensitivity, large dynamic range, and accuracy has led to the development of numerous applications with an increasing number of samples to be analyzed.

By End Users:

  • Hospitals and Laboratories
  • Pharmaceutical Companies
  • Academics
  • Others

In 2018, academics segment gained the highest market share for qPCR and dPCR market due to increased use of technology in the field of research.

By Regions:

  • North America
  • Europe
  • APAC
  • ROW

The market is dominated by North America, followed by Europe and Asia Pacific. The major share of the North America market is from the US due to the quick adoption of new and advanced technologies.

qPCR and dPCR Market Research Competitive Analysis - The PCR is a matured technology, innovation in the instruments, reagents, and software is essential to maintain their market position. However, this doesn't signify lack of improvement in both instruments and reagents. Superior sensitivity, improved multiplexing, better cDNA synthesis, and greater projectivity are the major features looked upon by the end-users of the market.

Merger and acquisition have been major strategy followed by key players in the market to maintain their leadership in the market. In 2016, Thermo Fisher Scientific deployed around $5.5 billion on acquisitions. This is expected to increase the offerings and strategic positioning of the company. The company increased its Life Sciences Solutions business by acquiring Affymetrix. In early 2017, Bio-Rad Laboratories, leader in digital PCR acquired RainDance Technologies, the fastest growing company in dPCR and liquid biopsy markets.

Key vendors:

  • Thermo Fisher Scientific
  • Bio-Rad Laboratories
  • Danaher Corp.
  • Agilent Technologies, Inc.
  • Qiagen N.V.
  • F. Hoffmann-La Roche
  • Abbott Laboratories
  • Promega Corp.
  • Eppendorf AG
  • BioMerieux S.A.
  • Merck KGaA

Key competitive facts
The market is highly competitive with all the players competing to gain market shares. Intense competition, rapid advancements in technology, and the prices are key factors that confront the market.
The requirement of high investment for the installation of the qPCR and specially the dPCR instruments are hampering the growth of the market.

The report provides complete details about the usage and adoption rate of qPCR and dPCR market. Thus, the key stakeholders can know about the major trends, drivers, investments, vertical player’s initiatives, and government initiatives towards the medical devices segment in the upcoming years along with details of the pureplay companies entering the market. Moreover, the report provides details about the major challenges that are going to impact the market growth. Additionally, the report gives complete details about the key business opportunities to stakeholders in order to expand their business and capture the revenue in specific verticals, and to analyze before investing or expanding the business in this market.

Key Takeaways:

  • Understanding the potential market opportunity with precise market size and forecast data
  • Detailed market analysis focusing on the growth of qPCR and dPCR industry
  • Factors influencing the growth of qPCR and dPCR market
  • In-depth competitive analysis of dominant and pure play vendors
  • Prediction analysis of qPCR and dPCR industry in both developed and developing regions
  • Key insights related to major segments of the qPCR and dPCR market
  • Latest market trend analysis impacting the buying behavior of the consumers
Note: Product cover images may vary from those shown
2 of 3


  • Abbott Laboratories
  • Agilent Technologies Inc.
  • BioMerieux S.A.
  • Bio-Rad Laboratories
  • Danaher Corp. (Cepheid)
  • Eppendorf AG
  • MORE

1 Industry Outlook
1.1 Industry Overview
1.2 Total Addressable Market
1.2.1 Industry Trends

2 Report Outline
2.1 Report Scope
2.2 Report Summary
2.3 Research Methodology
2.4 Report Assumptions

3 Market Snapshot
3.1 Market Definition
3.2 Segmented Addressable Market (SAM)
3.2.1 Strengths of dPCR and qPCR
3.2.2 Application of Digital PCR Applications
3.2.3 Emerging Applications of Droplet Digital PCR
3.3 Industry Trends
3.4 Related Markets
3.4.1 In-Vitro Diagnostics Industry trends
3.4.2 Liquid Biopsy Market Trends of liquid biopsy market
3.4.3 Next-Generation Sequencing Trends in the next-generation sequencing market

4 Market Outlook
4.1 Infectious Diseases detected by qPCR and ddPCR
4.2 Porter 5 (Five) Forces

5 Market Characteristics
5.1 Evolution
5.2 Market Segmentation
5.3 Market Dynamics
5.3.1 Drivers Rising demand for qPCR and dPCR in genetic and molecular testing Increasing in private investment and funds Increasing demand for biomarker-based tests
5.3.2 Restraints Lack of skilled professionals High cost of the qPCR and dPCR instruments
5.3.3 Opportunities Growth of personalized medicines Market expansion opportunities in emerging nations
5.3.4 DRO – Impact Analysis
5.4 Key Stakeholders

6 Technology Types: Market Size and Analysis
6.1 Overview
6.2 Digital Polymerase Chain Reaction
6.3 Real-Time/Quantitative Polymerase Chain Reaction

7 Product Types: Market Size and Analysis
7.1 Overview
7.2 Instrument
7.3 Reagents and Consumables
7.4 Software and Services

8 Application: Market Size and Analysis
8.1 Overview
8.2 Clinical Diagnostics
8.3 Biomedical Research
8.4 Others

9 End Users: Market Size and Analysis
9.1 Overview
9.2 Hospitals and Laboratories
9.3 Pharmaceutical Companies
9.4 Academics
9.5 Others

10 Regions: Market Size and Analysis
10.1 Overview
10.2 North America
10.2.1 Overview
10.3 Europe
10.3.1 Overview
10.4 Asia Pacific
10.4.1 Overview
10.5 Rest of the World
10.5.1 Overview

11 Competitive Landscape
12 Vendors Profile
12.1 Thermo Fisher Scientific, Inc.
12.1.1 Overview
12.1.2 Business Units
12.1.3 Geographic Revenue
12.1.4 Business Focus
12.1.5 SWOT Analysis
12.1.6 Business Strategy
12.2 F. Hoffmann-La Roche Ltd.
12.2.1 Overview
12.2.2 Business Units
12.2.3 Geographic Revenue
12.2.4 Business Focus
12.2.5 SWOT Analysis
12.2.6 Business Strategies
12.3 Abbott Laboratories
12.3.1 Overview
12.3.2 Business Units
12.3.3 Geographic Revenue
12.3.4 Business Focus
12.3.5 SWOT Analysis
12.3.6 Business Strategies
12.4 Qiagen N.V.
12.4.1 Overview
12.4.2 Business Units
12.4.3 Geographic Revenue
12.4.4 Business Focus
12.4.5 SWOT Analysis
12.4.6 Business Strategies
12.5 Bio-Rad Laboratories
12.5.1 Overview
12.5.2 Business Units
12.5.3 Geographic Revenue
12.5.4 Business Focus
12.5.5 SWOT Analysis
12.5.6 Business Strategies

13 Companies to Watch for
13.1 Agilent Technologies Inc.
13.1.1 Overview
13.2 Promega Corp.
13.2.1 Overview
13.3 Eppendorf AG
13.3.1 Overview
13.4 BioMerieux S.A.
13.4.1 Overview
13.5 Merck KGaA
13.5.1 Overview
13.6 Danaher Corp. (Cepheid)
13.6.1 Overview

List of Tables
Table 1 Global QPCR And DPCR Market Revenue, By Product Type, 2018–2025 ($Million)
Table 2 QPCR And DPCR Market Revenue, By Product Type, 2018–2025 ($Million)
Table 3 Global QPCR And DPCR Market Revenue, By Product Type, 2018–2025 ($Million)
Table 4 Suitability Of DPCR And QPCR For Major Applications
Table 5 Other Prominent Vendors
Table 6 Thermo Fisher Scientific Inc.: Product Offerings
Table 7 Thermo Fisher Scientific: Recent Developments
Table 8 F. Hoffmann-La Roche Ltd.: Product Offerings
Table 9 F. Hoffmann-La Roche Ltd.: Recent Developments
Table 10 Abbott Laboratories: Product Offerings
Table 11 Abbott Laboratories: Recent Developments
Table 12 Qiagen N.V.: Offerings
Table 13 Qiagen N.V.: Recent Developments
Table 14 Bio-Rad Laboratories: Offerings
Table 15 Bio-Rad Laboratories: Recent Developments
Table 16 Agilent Technologies Inc.: Snapshot
Table 17 Agilent Technologies Inc.: Recent Developments
Table 18 Promega Corp.: Overview
Table 19 Promega Corp.: Recent Developments
Table 20 Eppendorf Ag: Overview
Table 21 Eppendorf Ag.: Recent Developments
Table 22 Biomerieux S.A.: Snapshot
Table 23 Biomerieux S.A.: Recent Developments
Table 24 Merck Kgaa: Overview
Table 25 Merck Kgaa.: Recent Developments
Table 26 Danaher Corp.: Overview
Table 27 Danaher Corp.: Recent Developments

List of Charts
Chart 1 Research Methodology Of Global QPCR And DPCR Market
Chart 2 Global QPCR And DPCR Market Revenue, 2018–2025 ($Million)
Chart 3 Porters 5 Forces On Global QPCR And DPCR Market
Chart 5 Global QPCR And DPCR Market Segmentation
Chart 6 Market Dynamics – Drivers, Restraints & Opportunities
Chart 7 Dro - Impact Analysis Of Global QPCR And DPCR Market
Chart 8 Key Stakeholders Of Global QPCR And DPCR Market
Chart 9 Global QPCR And DPCR Market Segment Revenue By Technology Type, 2018 Vs 2025 ($Million)
Chart 10 Digital Pcr Instrument Market Revenue, By Types 2018–2025 ($Million)
Chart 11 Real Time/Quantitative Pcr Instrument Market Revenue, By Types 2018–2025 ($Million)
Chart 12 QPCR And DPCR Market Segment Revenue By Product Type, 2018 Vs 2025 ($ Million)
Chart 13 QPCR And DPCR Instrument Market Revenue, By Product Types 2018–2025 ($Million)
Chart 14 QPCR And DPCR Reagents And Consumables Market Revenue, By Product Type 2018-2025 ($Million)
Chart 15 QPCR And DPCR Software And Services Market Revenue, By Product Type 2018-2025 ($Million)
Chart 16 QPCR And DPCR Market Segment Revenue By Application Types, 2018 (%)
Chart 17 Global QPCR And DPCR Market Segment Revenue By End Users, 2018 (%)
Chart 18 QPCR And DPCR Market By Regional Segmentation, 2018 Vs 2025 ($Million)
Chart 19 QPCR And DPCR Market Revenue In North America, 2018–2025 ($Million)
Chart 20 QPCR And DPCR Market Revenue In Europe, 2018–2025 ($Million)
Chart 21 QPCR And DPCR Market Revenue In Asia Pacific, 2018–2025 ($Million)
Chart 22 QPCR And DPCR Revenue In Rest Of The World, 2018–2025 ($Million)
Chart 23 Thermo Fisher Scientific Inc.: Overview Snapshot
Chart 24 Thermo Fisher Scientific Inc.: Business Units
Chart 25 Thermo Fisher Scientific Inc.: Geographic Revenue
Chart 26 Thermo Fisher Scientific Inc.: Swot Analysis
Chart 27 F. Hoffmann-La Roche Ltd.: Overview Snapshot
Chart 28 F. Hoffmann-La Roche Ltd.: Business Units
Chart 29 F. Hoffmann-La Roche Ltd.: Geographic Revenue
Chart 30 F. Hoffmann-La Roche Ltd.: Swot Analysis
Chart 31 Abbott Laboratories: Overview Snapshot
Chart 32 Abbott Laboratories: Business Units
Chart 33 Abbott Laboratories: Geographic Revenue
Chart 34 Abbott Laboratories: Swot Analysis
Chart 35 Qiagen N.V.: Overview Snapshot
Chart 36 Qiagen N.V.: Business Units
Chart 37 Qiagen N.V.: Geographic Revenue
Chart 38 Qiagen N.V.: Swot Analysis
Chart 39 Bio-Rad Laboratories: Overview Snapshot
Chart 40 Bio-Rad Laboratories: Business Units
Chart 41 Bio-Rad Laboratories: Geographic Revenue
Chart 42 Bio-Rad Laboratories: Swot Analysis

Note: Product cover images may vary from those shown
3 of 3
  • Abbott Laboratories
  • Agilent Technologies Inc.
  • Bio-Rad Laboratories
  • BioMerieux S.A.
  • Danaher Corp. (Cepheid)
  • Eppendorf AG
  • F. Hoffmann-La Roche Ltd.
  • Merck KGaA
  • Promega Corp.
  • Qiagen N.V.
  • Thermo Fisher Scientific, Inc.
Note: Product cover images may vary from those shown